Preliminary evidence for a role of apolipoprotein E alleles in identifying haemodialysis patients at high vascular risk

Nephrology Dialysis Transplantation

Volumn 12, Issue 4, 1997, Pages 691-693

  Olmer, M ^a   Renucci, J E ^a   Planells, R ^a   Bouchouareb, D ^a   Purgus, R ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Apolipoprotein E4; Atherosclerosis risk; Dialysis; Dyslipidaemia; End stage renal failure; Genetic factor

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CAROTID ARTERY; DYSLIPIDEMIA; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CAROTID ARTERY, COMMON; COHORT STUDIES; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; VASCULAR DISEASES;

EID: 0030981817     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.4.691     Document Type: Article

References (14)

1. Cheung AK, Wu LL, Kablitz C, Leypolot JK. Atherogenic lipids and lipoproteins in hemodialysis patients. Am J Kidney Dis 1993; 2: 271-276
2. Krol E, Rutkowski B, Wroblewska M, Badzio T. Classification of lipid disorders in chronic hemodialyzed patients. Miner Electrolyte Metab 1996; 22: 13-15
3. Mittman N, Avram MM. Dyslipidemia in renal disease. Semin Nephrol 1996; 3: 202-213
4. Kronenberg F, Utermann G, Dieplinger H. Lipoprotein (a) in renal disease. Am J Kidney Dis 1996; 1: 1-25
5. Yang WS, Kim SB, Min WK, Park S, Lee MS, Park JS. Atherogenic lipid profile and lipoprotein (a) in relation to serum albumin in haemodialysis patients. Nephrol Dial Transplant 1995; 10: 1668-1671
6. Roth DD. Is atherogenesis accelerated in hemodialysis patients? Intern J Artif Org 1992; 6: 323-326
7. Utermann G, Hardeing A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 1984; 65: 237-241
8. Snyder SM, Chan B, Hubl ST, Young SG. Relationship of apolipoprotein E phenotypes to hypocholesterolemia. Am J Med 1993; 95: 480-488
9. Walden CC, Hegele RA. Apolipoprotein E in hyperlipidemia. Ann Intern Med 1994; 120: 1026-1036
10. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1991; 31: 545-548
11. Salonen R. Arterial wall thickness and carotid atherosclerosis (abst) First International Symposium. From arterial wall thickening to clinical symptom. July 1995, Paris, France
12. Rossi A, Bonfante L, Giacomini A, Calabro A, Rossi G, Sailer A, Abbruzzese E, Baldo G, Mastrosimone S, Beccari A, Baiocchi MR, de Silvestro L, Roncali D, Boizonella R, Gardin C, Bordin V, Antonello A, Normanno M, Crepaldi G, Borsatti A. Carotid artery lesions in patients with nondiabetic chronic renal failure. Am J Kidney Dis 1986; 1: 58-66
13. Perret F, Depairon M, Bovet P, Darioli R, Despland P, Abel M, Kappenberger I. Carotid and femoral intima-media thickness (IMT) in the Seychelles heart study 1994: reproducibility and mean values according to age and sex. 1st International Symposium on arterial wall thickening, 1995, July, Paris, France
14. Lee JS, Ryu JS, Kweon TW, Yang WS, Kim SB, Min WK, Park JS. Apolipoprotein E genotype, Lipoprotein (a) and atherosclerotic cardiovascular disease in CAPD patients. J Am Soc Nephrol 1996; 9: 1454